NPI registry status
Active
2026 NPPES data Urology Physician NPI 1053315077 MD
Verify on CMS → Jeffrey Rebman, MD
Urology Physician in North Chesterfield, Virginia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 13,606 in Urology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
6K
Medicare Part D claims · 1K beneficiaries · Urology Physician avg: 1K
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
71.6/100
▼ 12 pts below national avg 83.5 · Mid-tier
Industry payments
$136.7
5 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Jeffrey Rebman, MD reported a CMS MIPS final score of 71.6/100 - below the 83.5 national average - and filed 6,130 Medicare Part D claims in 2024.
- 71.6/100
- MIPS score · -12 vs avg
- 6K
- Part D claims, 2024
- 95%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jeffrey Rebman, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1053315077), first enumerated 06/08/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 6,130 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 71.6/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$136.7 in reported industry payments (5 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1053315077 · Urology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1053315077
- ENUM-LEGACY 2005
- TAX-MID 14K Urology Physician
- MIPS-LOW 71.6/100
- RX-MID 6,130
- BOOK-THIN 341 in Virginia
- PHOTO-FINISH Joseph Trapasso, MD · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Joseph Trapasso,…
Joseph Trapasso, MD
71.5 MIPS pts
- Rebman · this pr…
Rebman · this provider
71.6 MIPS pts
- Brian Cross, M.D…
Brian Cross, M.D.
71.7 MIPS pts
- Nathan Bradley, …
Nathan Bradley, MD
71.7 MIPS pts
- Michael Cookson,…
Michael Cookson, MD
71.7 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Jeffrey Rebman, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
72 ≥ 9th percentile 9% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jeffrey Rebman, MD sits
This provider among urology physician peers
Across the 4,091 urology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jeffrey Rebman, MD writes more Part D claims than 99% of them and scores higher on MIPS quality than 9% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one urology physician peer from a representative sample of 60; the gold marker is Jeffrey Rebman, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Jeffrey Rebman, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jeffrey Rebman, MD?
Below national averagePrimary specialty
Urology Physician
Medicare Part D claims
6,130 353% vs specialty avg
MIPS final score
71.6/100 11.9 pts vs avg
Specialty distribution in Virginia
How Urology Physician compares to other specialties among Virginia providers
Medicare quality performance, MIPS
Jeffrey Rebman, MD's 2023 MIPS final score plotted against the Urology Physician national average
- MIPS Final Score
- 71.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1053315077 |
|---|---|
| Specialty | Urology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 06/08/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
71.5781
Final Score
Measured-score avg: 83.5
58.6902
Quality
60.34
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jeffrey Rebman, MD. Source: openpaymentsdata.cms.gov.
Total received
$137
Largest payer
ACCORD HEALTHCARE, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Jeffrey Rebman, MD - brand share 5.0%
Urology Physician average
5% brand-name claims vs 95% generic, on 6,130 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
6,130
Total Claims
$299K
Total Drug Cost
1,128
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 14,255.4
- Total Day Supply
- 419,849
- Brand vs Generic
- 5% brand / 95% generic
- Brand Drug Cost
- $157K
- Generic Drug Cost
- $142K
- Antibiotic Claims
- 1,230
Patient Demographics
- Average Patient Age
- 75.7 years
- Avg HCC Risk Score
- 1.14
- Gender Split
- 16% female / 84% male
- Age Distribution
- <65: 49, 65-74: 452, 75-84: 467, 85+: 160
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Jeffrey Rebman, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Finasteride
Finasteride
1,546 claims
- Tamsulosin Hcl
Tamsulosin Hcl
1,430 claims
- Alfuzosin Hcl Er 493
Alfuzosin Hcl Er
493 claims
- Doxycycline Hyclate 374
Doxycycline Hyclate
374 claims
- Oxybutynin Chlorid… 323
Oxybutynin Chloride Er
323 claims
- Amoxicillin-Clavul… 273
Amoxicillin-Clavulanate Potass
273 claims
- Nitrofurantoin Mon… 155
Nitrofurantoin Mono-Macro
155 claims
- Solifenacin Succin… 129
Solifenacin Succinate
129 claims
| Drug | Claims |
|---|---|
| Finasteride | 1,546 |
| Tamsulosin Hcl | 1,430 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 493 |
| Doxycycline Hyclate | 374 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 323 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 273 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 155 |
| Solifenacin Succinate | 129 |
| Cephalexin | 116 |
| Myrbetriq Mirabegron | 114 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How Jeffrey Rebman, MD fits within the Urology Physician landscape nationally.
13,606
Urology Physician Providers in US
54
States with Urology Physician
1,354
Avg Claims per Provider
Jeffrey Rebman, MD's 6,130 claims are above the specialty average of 1,354.
Nationwide Urology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Rebman, both outside Virginia so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (71.6 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Urology Physician Providers in Virginia
Other clinicians with the same primary specialty enrolled in Virginia, drawn from the same CMS NPPES roster as Rebman.
One of 341 Urology Physician providers enrolled in Virginia, 5 are shown here.
Dr. Nassib Abou Heidar
MD
Charlottesville, VA
Dr. Mehrad Adibi
MD
Roanoke, VA
Dr. Joel Alperstein
MD
Fairfax, VA
Dr. Basavlinga Amarkumar
M.D.
Salem, VA
Dr. Mark Anderson
M.D., M.SC.
Charlottesville, VA
Compare Urology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Jeffrey Rebman, MD's specialty? ▼
Jeffrey Rebman, MD specializes in Urology Physician and practices in North Chesterfield, Virginia. Credentials: MD.
How much does Jeffrey Rebman, MD prescribe under Medicare Part D? ▼
In 2024, Jeffrey Rebman, MD wrote 6,130 Medicare Part D claims totaling $299K in drug costs for 1,128 beneficiaries.
What is Jeffrey Rebman, MD's Medicare quality score? ▼
Jeffrey Rebman, MD has a CMS MIPS Final Score of 71.6/100 (Quality: 58.7, Cost: 60.3). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jeffrey Rebman, MD located? ▼
Jeffrey Rebman, MD is located at 1401 JOHNSTON WILLIS DR STE 2100, North Chesterfield, VA, 23235. Phone: (804) 320-1355.
What is Jeffrey Rebman, MD's NPI number? ▼
Jeffrey Rebman, MD's National Provider Identifier (NPI) is 1053315077, issued on 06/08/2005.
Does Jeffrey Rebman, MD prescribe more brand-name or generic drugs? ▼
Jeffrey Rebman, MD's prescribing is 5% brand-name and 95% generic drugs by claim count, with $157K in brand drug costs.
How many Urology Physician providers are there in the US? ▼
There are 13,606 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,354 Medicare Part D claims per year.
What drugs does Jeffrey Rebman, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Jeffrey Rebman, MD's most frequently prescribed drugs include Finasteride, Tamsulosin Hcl, Alfuzosin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jeffrey Rebman, MD accept Medicare? ▼
Jeffrey Rebman, MD appears in CMS Medicare data with 6,130 Part D claims and 1,128 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jeffrey Rebman, MD's credentials? ▼
Jeffrey Rebman, MD's NPI is 1053315077 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.